AstraZeneca drug Fasenra fails to achieve main goal in COPD trial - Nano News Online

Wednesday, May 30, 2018

AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

(Reuters) - AstraZeneca's first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD).


from Reuters: Health News https://ift.tt/2xpFMtx

No comments:

Post a Comment